Results
Neuland Laboratories Q2 Revenue Down 11.4% YoY
Neuland Laboratories reported Q2 FY27 standalone revenue of ₹457.2 Cr, down 11.4% YoY due to operating deleverage.
EBITDA declined 33.4% YoY to ₹104.6 Cr with margin contraction of 754 basis points to
